Publicação: 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
dc.contributor.author | Rider, Lisa G. | |
dc.contributor.author | Aggarwal, Rohit | |
dc.contributor.author | Pistorio, Angela | |
dc.contributor.author | Bayat, Nastaran | |
dc.contributor.author | Erman, Brian | |
dc.contributor.author | Feldman, Brian M. | |
dc.contributor.author | Huber, Adam M. | |
dc.contributor.author | Cimaz, Rolando | |
dc.contributor.author | Cuttica, Ruben J. | |
dc.contributor.author | Oliveira, Sheila Knupp de | |
dc.contributor.author | Lindsley, Carol B. | |
dc.contributor.author | Pilkington, Clarissa A. | |
dc.contributor.author | Punaro, Marilynn | |
dc.contributor.author | Ravelli, Angelo | |
dc.contributor.author | Reed, Ann M. | |
dc.contributor.author | Rouster-Stevens, Kelly | |
dc.contributor.author | van Royen-Kerkhof, Annet | |
dc.contributor.author | Dressler, Frank | |
dc.contributor.author | Magalhaes, Claudia Saad [UNESP] | |
dc.contributor.author | Constantin, Tamas | |
dc.contributor.author | Davidson, Joyce E. | |
dc.contributor.author | Magnusson, Bo | |
dc.contributor.author | Russo, Ricardo | |
dc.contributor.author | Villa, Luca | |
dc.contributor.author | Rinaldi, Mariangela | |
dc.contributor.author | Rockette, Howard | |
dc.contributor.author | Lachenbruch, Peter A. | |
dc.contributor.author | Miller, Frederick W. | |
dc.contributor.author | Vencovsky, Jiri | |
dc.contributor.author | Ruperto, Nicolino | |
dc.contributor.author | Int Myositis Assessment Clinical | |
dc.contributor.author | Paediat Rheumatology Int Trials | |
dc.contributor.institution | NIEHS | |
dc.contributor.institution | Univ Pittsburgh | |
dc.contributor.institution | Ist Giannina Gaslini | |
dc.contributor.institution | Social & Sci Syst Inc | |
dc.contributor.institution | Hosp Sick Children | |
dc.contributor.institution | IWK Hlth Ctr | |
dc.contributor.institution | Univ Florence | |
dc.contributor.institution | Univ Buenos Aires | |
dc.contributor.institution | Universidade Federal do Rio de Janeiro (UFRJ) | |
dc.contributor.institution | Univ Kansas City | |
dc.contributor.institution | Great Ormond St Hosp Sick Children | |
dc.contributor.institution | Univ Texas Southwestern Med Ctr Dallas | |
dc.contributor.institution | Univ Genoa | |
dc.contributor.institution | Duke Univ | |
dc.contributor.institution | Emory Univ | |
dc.contributor.institution | Univ Med Ctr Utrecht | |
dc.contributor.institution | Hannover Med Sch | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Semmelweis Univ | |
dc.contributor.institution | Royal Hosp Sick Children | |
dc.contributor.institution | Karolinska Univ Hosp | |
dc.contributor.institution | Hosp Pediat Garrahan | |
dc.contributor.institution | PRINTO | |
dc.contributor.institution | Charles Univ Prague | |
dc.date.accessioned | 2018-11-28T10:07:48Z | |
dc.date.available | 2018-11-28T10:07:48Z | |
dc.date.issued | 2017-05-01 | |
dc.description.abstract | Objective. To develop response criteria for juvenile dermatomyositis (DM). Methods. We analyzed the performance of 312 definitions that used core set measures from either the International Myositis Assessment and Clinical Studies Group (IMACS) or the Paediatric Rheumatology International Trials Organisation (PRINTO) and were derived from natural history data and a conjoint analysis survey. They were further validated using data from the PRINTO trial of prednisone alone compared to prednisone with methotrexate or cyclosporine and the Rituximab in Myositis (RIM) trial. At a consensus conference, experts considered 14 top candidate criteria based on their performance characteristics and clinical face validity, using nominal group technique. Results. Consensus was reached for a conjoint analysis-based continuous model with a total improvement score of 0-100, using absolute percent change in core set measures of minimal (>= 30), moderate (>= 45), and major (>= 70) improvement. The same criteria were chosen for adult DM/polymyositis, with differing thresholds for improvement. The sensitivity and specificity were 89% and 91-98% for minimal improvement, 92-94% and 94-99% for moderate improvement, and 91-98% and 85-86% for major improvement, respectively, in juvenile DM patient cohorts using the IMACS and PRINTO core set measures. These criteria were validated in the PRINTO trial for differentiating between treatment arms for minimal and moderate improvement (P=0.009-0.057) and in the RIM trial for significantly differentiating the physician's rating for improvement (P<0.006). Conclusion. The response criteria for juvenile DM consisted of a conjoint analysis-based model using a continuous improvement score based on absolute percent change in core set measures, with thresholds for minimal, moderate, and major improvement. | en |
dc.description.affiliation | NIEHS, NIH, Bethesda, MD USA | |
dc.description.affiliation | Univ Pittsburgh, Pittsburgh, PA USA | |
dc.description.affiliation | Ist Giannina Gaslini, Serv Epidemiol & Biostat, Genoa, Italy | |
dc.description.affiliation | Social & Sci Syst Inc, Durham, NC USA | |
dc.description.affiliation | Hosp Sick Children, Toronto, ON, Canada | |
dc.description.affiliation | IWK Hlth Ctr, Halifax, NS, Canada | |
dc.description.affiliation | Univ Florence, Florence, Italy | |
dc.description.affiliation | Univ Buenos Aires, Hosp Ninos Pedro de Elizalde, Buenos Aires, DF, Argentina | |
dc.description.affiliation | Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil | |
dc.description.affiliation | Univ Kansas City, Med Ctr, Kansas City, KS USA | |
dc.description.affiliation | Great Ormond St Hosp Sick Children, London, England | |
dc.description.affiliation | Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA | |
dc.description.affiliation | Univ Genoa, Pediat Reumatol 2, Ist Giannina Gaslini, Genoa, Italy | |
dc.description.affiliation | Duke Univ, Durham, NC USA | |
dc.description.affiliation | Emory Univ, Sch Med, Atlanta, GA USA | |
dc.description.affiliation | Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands | |
dc.description.affiliation | Hannover Med Sch, Hannover, Germany | |
dc.description.affiliation | Univ Estadual Paulista, Botucatu, SP, Brazil | |
dc.description.affiliation | Semmelweis Univ, Budapest, Hungary | |
dc.description.affiliation | Royal Hosp Sick Children, Glasgow, Lanark, Scotland | |
dc.description.affiliation | Royal Hosp Sick Children, Edinburgh, Midlothian, Scotland | |
dc.description.affiliation | Karolinska Univ Hosp, Stockholm, Sweden | |
dc.description.affiliation | Hosp Pediat Garrahan, Buenos Aires, DF, Argentina | |
dc.description.affiliation | PRINTO, Ist Giannina Gaslini, Pediat Reumatol 2, Genoa, Italy | |
dc.description.affiliation | Charles Univ Prague, Prague, Czech Republic | |
dc.description.affiliationUnesp | Univ Estadual Paulista, Botucatu, SP, Brazil | |
dc.description.sponsorship | American College of Rheumatology | |
dc.description.sponsorship | European League Against Rheumatism | |
dc.description.sponsorship | NIH (National Institute of Environmental Health Sciences [NIEHS]) | |
dc.description.sponsorship | NIH (National Center for Advancing Translational Sciences) | |
dc.description.sponsorship | NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases) | |
dc.description.sponsorship | Istituto G. Gaslini | |
dc.description.sponsorship | Paediatric Rheumatology International Trials Organisation (PRINTO) | |
dc.description.sponsorship | Cure JM Foundation | |
dc.description.sponsorship | Myositis UK | |
dc.description.sponsorship | Myositis Association | |
dc.description.sponsorship | Ministry of Health, Czech Republic (Institute of Rheumatology project for conceptual development of a research organization) | |
dc.description.sponsorshipId | Ministry of Health, Czech Republic (Institute of Rheumatology project for conceptual development of a research organization): 00023728 | |
dc.format.extent | 911-923 | |
dc.identifier | http://dx.doi.org/10.1002/art.40060 | |
dc.identifier.citation | Arthritis & Rheumatology. Hoboken: Wiley, v. 69, n. 5, p. 911-923, 2017. | |
dc.identifier.doi | 10.1002/art.40060 | |
dc.identifier.issn | 2326-5191 | |
dc.identifier.lattes | 7098310008371632 | |
dc.identifier.orcid | 0000-0002-7631-7093 | |
dc.identifier.uri | http://hdl.handle.net/11449/165585 | |
dc.identifier.wos | WOS:000400068300005 | |
dc.language.iso | eng | |
dc.publisher | Wiley-Blackwell | |
dc.relation.ispartof | Arthritis & Rheumatology | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Web of Science | |
dc.title | 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative | en |
dc.type | Artigo | |
dcterms.license | http://olabout.wiley.com/WileyCDA/Section/id-406071.html | |
dcterms.rightsHolder | Wiley-Blackwell | |
dspace.entity.type | Publication | |
unesp.author.lattes | 7098310008371632[19] | |
unesp.author.orcid | 0000-0002-6895-8720[3] | |
unesp.author.orcid | 0000-0002-1256-8483[23] | |
unesp.author.orcid | 0000-0002-7631-7093[19] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Pediatria - FMB | pt |